← Latest papers
📄 medicine

Net Calcium Balance in Hemodialysis and Hemodiafiltration Patients: The Predominant Role of Dialysate Calcium Mass Transfer over Dietary and Modality Factors

This cross-sectional study of Iranian dialysis patients reveals that dialysate calcium mass transfer is the predominant factor determining whole-body calcium balance, outweighing the influence of dietary intake, calcium supplementation, and the choice between hemodialysis and hemodiafiltration.

Original authors: Somaye-Sadat Heidari, Marieh Farrokhy-Moghaddam, Mohsen Nafar, Nasrin Borumandnia, Azita Hekmatdoost, Nooshin Dalili, Fatemeh Poor-rezagholi, Ahmad Firoozan, Fariba Samadian, Sahand Ameri, Mahsa Hosse
Published 2026-09-14
📖 5 min read🧠 Deep dive

Original authors: Somaye-Sadat Heidari, Marieh Farrokhy-Moghaddam, Mohsen Nafar, Nasrin Borumandnia, Azita Hekmatdoost, Nooshin Dalili, Fatemeh Poor-rezagholi, Ahmad Firoozan, Fariba Samadian, Sahand Ameri, Mahsa Hosseini Chimeh, Shiva Samavat

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

For millions of people living with advanced kidney failure, the body's ability to filter waste and balance minerals has shut down. Without functioning kidneys, the blood becomes a crowded, unbalanced place where calcium, a mineral essential for strong bones and a steady heartbeat, can drift dangerously out of control. Too little calcium in the blood signals the bones to dissolve themselves to release more, leading to brittle fractures. Too much calcium, however, can settle into the soft tissues of the heart and blood vessels, causing them to stiffen and fail. Doctors have long relied on a simple blood test to gauge this balance, but that snapshot often misses the bigger picture. It cannot tell if a patient is slowly gaining calcium from their diet and treatment, or slowly losing it, a hidden drift that eventually leads to severe health crises. Understanding the true, daily movement of calcium in and out of the body is the key to keeping these patients safe, yet measuring this invisible flow has remained a difficult puzzle.

In a recent study conducted at dialysis centers in Tehran, Iran, a team of researchers set out to solve this puzzle by tracking the actual journey of calcium in patients undergoing two different types of life-sustaining treatments: hemodialysis and hemodiafiltration. These treatments act as artificial kidneys, cleaning the blood through a machine that pumps it through a filter. The researchers wanted to know exactly how much calcium patients were taking in through food and pills, and how much was being added to or removed from their bodies by the treatment fluid itself. They followed 121 patients, carefully recording what they ate over several days, counting the calcium in their supplements, and measuring the calcium levels in the fluid that left the machine after each session. By adding up the intake and subtracting the losses through stool and skin, they calculated a daily "net balance" for each person, revealing whether they were in a state of gaining or losing calcium.

The results painted a clear picture of a population split almost evenly between those gaining calcium and those losing it. About half of the patients were in a positive balance, meaning their bodies were accumulating more calcium than they were shedding. The other half were in a negative balance, slowly losing the mineral. The study found that the most powerful driver of this balance was not what the patients ate, nor their age or how long they had been on dialysis, but rather the calcium mass transfer. This term describes the net amount of calcium that moves between the patient's blood and the cleaning fluid during a treatment session. The researchers discovered that for every small increase in the amount of calcium transferred from the fluid into the blood, the likelihood of a patient having a positive balance grew significantly. This finding suggests that the dialysis fluid itself is the dominant force shaping the body's calcium levels, often outweighing dietary choices.

While diet and supplements played a role, their influence was secondary to the treatment mechanics. Patients who took calcium supplements were more likely to have a positive balance, but the sheer volume of calcium moving across the dialysis filter was the strongest predictor. The study also highlighted a distinct difference between the two types of treatments used. Patients receiving hemodiafiltration, a more advanced form of treatment that uses a larger volume of fluid and different flow dynamics, were far less likely to accumulate excess calcium compared to those on standard hemodialysis. Even though both groups used the same concentration of calcium in their cleaning fluid, the hemodiafiltration group tended to lose more calcium or gain less, resulting in a lower risk of a positive balance. This suggests that the method of treatment itself changes how the body interacts with the mineral, independent of the fluid's composition.

The researchers also looked at the health markers of those with negative balances and found they had higher levels of phosphorus and a protein called C-reactive protein, which signals inflammation in the body. This connection hints that chronic inflammation and high phosphorus levels might interfere with how the body handles calcium, potentially making it harder to absorb or retain the mineral. However, the study did not find that common demographic factors like age, gender, or body weight determined whether a patient would gain or lose calcium. Instead, the outcome was driven by modifiable factors: the specific treatment method, the amount of calcium transferred during the session, and the use of supplements.

These findings offer a new perspective for doctors managing kidney failure. Rather than relying solely on blood tests or dietary advice, the study suggests that the prescription of the dialysis fluid and the choice of treatment method are critical levers for controlling calcium levels. The authors emphasize that because the calcium transfer during dialysis is the strongest factor, treatments should be tailored to each patient's needs to avoid the dangers of both too much and too little calcium. While the study provides a strong snapshot of these relationships, the researchers note that future work is needed to confirm whether adjusting these specific factors leads to better long-term health outcomes. For now, the study clarifies that in the complex world of kidney failure, the flow of calcium through the dialysis machine is the primary current shaping the patient's mineral health.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →